Reappraisal of the Genetic Diversity and Pharmacogenetic Assessment of CES1

References

• Imai T , TaketaniM , ShiiM , HosokawaM , ChibaK . Substrate specificity of carboxylesterase isozymes and their contribution to hydrolase activity in human liver and small intestine . Drug Metab. Dispos.34 , 1734 – 1741 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Rasmussen HB , BjerreD , LinnetKet al. Individualization of treatments with drugs metabolized by CES1: combining genetics and metabolomics . Pharmacogenomics16 , 649 – 665 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Sun Z , MurryDJ , SanghaniSPet al. Methylphenidate is stereoselectively hydrolyzed by human carboxylesterase CES1A1 . J. Pharmacol. Exp. Ther.310 , 469 – 476 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Takai S , MatsudaA , UsamiYet al. Hydrolytic profile for ester- or amide-linkage by carboxylesterases pI 5.3 and 4.5 from human liver . Biol. Pharm. Bull.20 , 869 – 873 ( 1997 ).
   PubMed Web of Science ®Google Scholar
• Thomsen R , RasmussenHB , LinnetK , INDICES Consortium . In vitro drug metabolism by human carboxylesterase 1: focus on angiotensin-converting enzyme inhibitors . Drug Metab. Dispos.42 , 126 – 133 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Zhu H-J , AppelDI , JohnsonJA , ChavinKD , MarkowitzJS . Role of carboxylesterase 1 and impact of natural genetic variants on the hydrolysis of trandolapril . Biochem. Pharmacol.77 , 1266 – 1272 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Zhu H-J , WangX , GawronskiBE , BrindaBJ , AngiolilloDJ , MarkowitzJS . Carboxylesterase 1 as a determinant of clopidogrel metabolism and activation . J. Pharmacol. Exp. Ther.344 , 665 – 672 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Shi D , YangJ , YangD , LeCluyseEL , BlackC , YouLet al. Anti-influenza prodrug oseltamivir is activated by carboxylesterase human carboxylesterase 1, and the activation is inhibited by antiplatelet agent clopidogrel . J. Pharmacol. Exp. Ther.319 , 1477 – 1484 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Quiroga AD , LehnerR . Role of endoplasmic reticulum neutral lipid hydrolases . Trends Endocrinol. Metab.22 , 218 – 225 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Friedrichsen M , PoulsenP , WojtaszewskiJ , HansenPR , VaagA , RasmussenHB . Carboxylesterase 1 gene duplication and mRNA expression in adipose tissue are linked to obesity and metabolic function . PLoS ONE8 , e56861 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Jernås M , OlssonB , ArnerPet al. Regulation of carboxylesterase 1 (CES1) in human adipose tissue . Biochem. Biophys. Res. Commun.383 , 63 – 67 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Nagashima S , YagyuH , TakahashiNet al. Depot-specific expression of lipolytic genes in human adipose tissues – association among CES1 expression, triglyceride lipase activity and adiposity . J. Atheroscler. Thromb.18 , 190 – 199 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Fukami T , NakajimaM , MaruichiTet al. Structure and characterization of human carboxylesterase 1A1, 1A2, and 1A3 genes . Pharmacogenet. Genomics18 , 911 – 920 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Rasmussen HB , MadsenMB , HansenPR , INDICES Consortium . Nomenclature for alleles of the human carboxylesterase 1 gene . Pharmacogenet. Genomics27 , 78 – 80 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Sanford JC , WangX , ShiJ , BarrieES , WangD , ZhuH-Jet al. Regulatory effects of genomic translocations at the human carboxylesterase-1 (CES1) gene locus . Pharmacogenet. Genomics26 , 197 – 207 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Wang X , WangG , ShiJet al. CES1 genetic variation affects the activation of angiotensin-converting enzyme inhibitors . Pharmacogenomics J.16 , 220 – 230 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Bruxel EM , Salatino-OliveiraA , GenroJPet al. Association of a carboxylesterase 1 polymorphism with appetite reduction in children and adolescents with attention-deficit/hyperactivity disorder treated with methylphenidate . Pharmacogenomics J.13 , 476 – 480 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Yoshimura M , KimuraT , IshiiM , IshiiK , MatsuuraT , GeshiEet al. Functional polymorphisms in carboxylesterase1A2 (CES1A2) gene involves specific protein 1 (Sp1) binding sites . Biochem. Biophys. Res. Commun.369 , 939 – 942 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Zhu H-J , BrindaB , FroehlichTE , MarkowitzJS . A discriminative analytical method for detection of CES1A1 and CES1A2/CES1A3 genetic variants . Pharmacogenet. Genomics22 , 215 – 218 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Bjerre D , RasmussenHB , The INDICES Consortium . Novel procedure with improved resolution and specificity for amplification and differentiation of variants of the gene encoding carboxylesterase 1 . Pharmacogenet. Genomics27 , 155 – 158 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Marsh S , XiaoM , YuJet al. Pharmacogenomic assessment of carboxylesterases 1 and 2 . Genomics84 , 661 – 668 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Yamada S , RichardsonK , TangMet al. Genetic variation in carboxylesterase genes and susceptibility to isoniazid-induced hepatotoxicity . Pharmacogenomics J.10 , 524 – 536 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Ye J , CoulourisG , ZaretskayaI , CutcutacheI , RozenS , MaddenTL . Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction . BMC Bioinformatics13 , 134 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Hinrichs AS , KarolchikD , BaertschRet al. The UCSC Genome Browser Database: update 2006 . Nucleic Acids Res.34 , D590 – D598 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• den Dunnen JT , AntonarakisSE . Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion . Hum. Mutat.15 , 7 – 12 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Purcell S , NealeB , Todd-BrownKet al. PLINK: a tool set for whole-genome association and population-based linkage analyses . Am. J. Hum. Genet.81 , 559 – 575 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Barrett JC , FryB , MallerJ , DalyMJ . Haploview: analysis and visualization of LD and haplotype maps . Bioinformatics21 , 263 – 265 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Scheet P , StephensM . A fast and flexible statistical model for large-scale population genotype data: applications to inferring missing genotypes and haplotypic phase . Am. J. Hum. Genet78 , 629 – 644 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Wang K , LiM , HakonarsonH . ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data . Nucleic Acids Res.38 , e164 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Capriotti E , CalabreseR , FariselliP , MartelliPL , AltmanRB , CasadioR . WS-SNPs&GO: a web server for predicting the deleterious effect of human protein variants using functional annotation . BMC Genomics14 , S6 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Grantham R . Amino acid difference formula to help explain protein evolution . Science185 , 862 – 864 ( 1974 ).
   PubMed Web of Science ®Google Scholar
• Hertz CL , ChristiansenSL , Ferrero-MilianiLet al. Next-generation sequencing of 34 genes in sudden unexplained death victims in forensics and in patients with channelopathic cardiac diseases . Int. J. Legal Med.129 , 793 – 800 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• van Spaendonck-Zwarts KY , van RijsingenIAW , van den BergMPet al. Genetic analysis in 418 index patients with idiopathic dilated cardiomyopathy: overview of 10 years’ experience . Eur. J. Heart Fail.15 , 628 – 636 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Adzhubei IA , SchmidtS , PeshkinLet al. A method and server for predicting damaging missense mutations . Nat. Methods7 , 248 – 249 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Kumar P , HenikoffS , NgPC . Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm . Nat. Protoc.4 , 1073 – 1081 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Thomas-Chollier M , HuftonA , HeinigMet al. Transcription factor binding predictions using TRAP for the analysis of ChIP-seq data and regulatory SNPs . Nat. Protoc.6 , 1860 – 1869 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Zhu H-J , PatrickKS , YuanH-Jet al. Two CES1 gene mutations lead to dysfunctional carboxylesterase 1 activity in man: clinical significance and molecular basis . Am. J. Hum. Genet.82 , 1241 – 1248 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Sai K , SaitoY , TatewakiNet al. Association of carboxylesterase 1A genotypes with irinotecan pharmacokinetics in Japanese cancer patients . Br. J. Clin. Pharmacol.70 , 222 – 233 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Cha YJ , JeongHE , ShinJGet al. Genetic polymorphisms of the carboxylesterase 1 (CES1) gene in a Korean population . Transl. Clin. Pharmacol.22 , 30 – 34 ( 2014 ).
   Google Scholar
• 1000 Genomes Project Consortium , AutonA , BrooksLDet al.A global reference for human genetic variation . Nature526 , 68 – 74 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Lewis JP , HorensteinRB , RyanKet al. The functional G143E variant of carboxylesterase 1 is associated with increased clopidogrel active metabolite levels and greater clopidogrel response . Pharmacogenet. Genomics23 , 1 – 8 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Nemoda Z , AngyalN , TarnokZ , GadorosJ , Sasvari-SzekelyM . Carboxylesterase 1 gene polymorphism and methylphenidate response in ADHD . Neuropharmacology57 , 731 – 733 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Tarkiainen EK , BackmanJT , NeuvonenM , NeuvonenPJ , SchwabM , NiemiM . Carboxylesterase 1 polymorphism impairs oseltamivir bioactivation in humans . Clin. Pharmacol. Ther.92 , 68 – 71 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Leong IUS , StuckeyA , LaiD , SkinnerJR , LoveDR . Assessment of the predictive accuracy of five in silico prediction tools, alone or in combination, and two metaservers to classify long QT syndrome gene mutations . BMC Med. Genet.16 , 34 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Paré G , ErikssonN , LehrTet al. Genetic determinants of dabigatran plasma levels and their relation to bleeding . Circulation127 , 1404 – 1412 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Bencharit S , EdwardsCC , MortonCLet al. Multisite promiscuity in the processing of endogenous substrates by human carboxylesterase 1 . J. Mol. Biol.363 , 201 – 214 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Hosokawa M , FurihataT , YaginumaYet al. Structural organization and characterization of the regulatory element of the human carboxylesterase (CES1A1 and CES1A2) genes . Drug Metab. Pharmacokinet.23 , 73 – 84 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• NCIB . dbSNP short gentetic variations . www.ncbi.nlm.nih.gov/projects/SNP/
   Google Scholar
• Hosokawa M . Structure and catalytic properties of carboxylesterase isozymes involved in metabolic activation of prodrugs . Molecules13 , 412 – 431 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Zhao B , SongJ , St ClairRW , GhoshS . Stable overexpression of human macrophage cholesteryl ester hydrolase results in enhanced free cholesterol efflux from human THP1 macrophages . Am. J. Physiol. Cell Physiol.292 , C405 – C412 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Crow JA , MiddletonBL , BorazjaniA , HatfieldMJ , PotterPM , RossMK . Inhibition of carboxylesterase 1 is associated with cholesteryl ester retention in human THP-1 monocyte/macrophages . Biochim. Biophys. Acta1781 , 643 – 654 ( 2008 ).
   PubMed Web of Science ®Google Scholar